Aarkstore Enterprise || Asian Vaccine Markets | Market Research Report
Aarkstore.com announce a new report through its vast collection of market research report :
Asian Vaccine Markets | Market Research Report
For All Related Reports Please Follow the Link:
http://www.aarkstore.com/reports/Asian-Vaccine-Markets-Market-Research-Report-114034.html
The Asian vaccines market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn’t stopped companies from investing in Asian vaccine markets.
The graying of the population in Asia and the growth in some regions such as India and China are primary indicators of the potential for vaccine markets. This has encouraged market participants to increase spending in research and development and distribution facilities in Asian countries. This report examines the market for vaccines used in humans for various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.
As part of its coverage, this report includes:
Estimated Market Sizes for Pediatric Preventive Vaccines by Type in Asia (Influenz, Hepatitis, HPV, Pneumococcal, Combinations, Other Childhood Diseases)
Estimated Market Sizes for Adult Preventive Vaccines by Type in Asia (Influenza, Hepatitis, HPV, Travel and Endemic, Others) 2006 – 2014
Total Vaccine Market and Projections for Asian Countries: India, China, Japan, Korea, Indonesia and Rest of Asia
Major Manufacturers’ Shares of the Asian Adult Preventive Vaccine Market, 2010
Profiles of Top Participating Companies
Discussion of Regulatory Trends and IP Trends
Disease Statistics and Government Immunization Information
Manufacturer Strategies in Asian Countries
Discussion of Current and Emerging Delivery Options Systems
Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine-preventable diseases and their resulting deaths are now rare in the developed world. However, developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry.
The following companies are profiled in this report:
Bavarian Nordic A/S
Baxter International
Crucell
Emergent Biosolutions
GlaxoSmithKline
Merck
Novartis
Pfizer Inc
Sanofi Pasteur
Sinovac Biotech, Ltd
For the purpose of this report, secondary research into company reports, medical journals, trade publications and government reports was combined with primary research interviews of executives in the industry. In addition to this report, Kalorama has published research on the European vaccine industry and a look at what vaccines are in the pipeline in the future. Please see our website, www.kaloramainformation.com for more details on these studies.
Processing your request, Please wait....
